Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01983943

Olive Oil and Cardiovascular Health

Effects of Hydroxytyrosol on Vascular Health

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to conduct a double-blind, randomized controlled trial (RCT), to determine if six month supplementation of olive oil can improve the health of the blood vessels and improve long term health of the heart and blood vessels, in patients requiring percutaneous coronary intervention (PCI).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHydroxytyrosol, the active ingredient in olive oil.A 40mg capsule will be taken once daily for 6 months.
DIETARY_SUPPLEMENTPlaceboA 40mg placebo will be taken once per day for 6 months.
BEHAVIORALNutrition counselingNutrition counseling on eating a healthy diet will be offered once at baseline.
DEVICEEndopatAn endopat test will be administered twice, once and baseline and once after 6 months of supplementation, to test endothelial function. This is a non-invasive test that takes about 15 minutes.

Timeline

Start date
2013-08-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-11-14
Last updated
2015-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01983943. Inclusion in this directory is not an endorsement.

Olive Oil and Cardiovascular Health (NCT01983943) · Clinical Trials Directory